Division of Surgical, Molecular and Ultrastructural Pathology University of Pisa Pisa University Hospital Research Doctorate.

Slides:



Advertisements
Similar presentations
Neoplasia II: Tumor Characteristics
Advertisements

TOP2A IS AN INDEPENDENT PREDICTOR OF SURVIVAL IN UNSELECTED BREAST CANCER Amit Pancholi Molecular Profiling of Breast Cancer: Predictive Markers of Long.
Coding Complex Morphologies in ICD-O-3
Breast Cancer. Introduction Most common female cancer Accounts for 32% of all female cancer 211,300 new cases yearly and rising 40,000 deaths yearly.
Oncology The study of cancer. What is cancer? Any malignant growth or tumor caused by abnormal and uncontrolled cell division May be a tumor but it doesn’t.
Connie Lee, M.D. UF Surgery
Breast Pathology Helge Stalsberg MD University Hospital of North Norway.
Breast Cancer Research Presented by Manish Modi Manish Modi Stevens Institute of Technology REU SUMMER 2005.
BIOC 401. Blood Sample To Detect Breast Cancer Cancer is actually a group of many related diseases that all have to do with cells. Cells are the very.
Breast Pathology Dr. M. Griffin.
Collecting Duct Carcinoma of Kidney Differential Diagnosis of Neoplasms Involving the Renal Medulla Merce Jorda, MD, PhD, † and Murugesan Manoharan, MD*
Metastatic Breast Cancer: One Size Does Not Fit All Clifford Hudis, M.D. Chief, Breast Cancer Medicine Service MSKCC.
Joint Hospital Surgical Grand Round 21 st July, 2012 RH.
1 Breast MP/H Task Force Multiple Primary Rules Histology Coding Rules 2007.
Genetic and Molecular Epidemiology
BREAST CANCER PROF.NAZEM SHAMS. IS IT A SERIOUS PROBLEM ??
Chapter 4 Essential Concepts in Molecular Pathology Companion site for Molecular Pathology Author: William B. Coleman and Gregory J. Tsongalis.
© Copyright 2003 Cardinal Health, Inc. or one of its subsidiaries. All rights reserved. PET in Breast Cancer Early detection of disease Precise Staging.
Breast Pathology Seminar CASE PRESENTATION PART 1 Elba Torres Matundan MD FCAP Victor Carlo Vargas MD FCAP.
IMPROVED BREAST CANCER DIAGNOSIS AND PROGNOSIS BY
Morphology of breast cancer
BREAST CANCER GROUP 6 :  Nuraini Ikqtiarzune Haryono( )  Tri Wahyu Ningsih ( )  Rani Yuswandaru ( )  Anita Rheza Fitriana Putri( )
Clinico-Pathological Conference (CPC) Meet Karpagam Medical College Hospital
How to manage suspected cancer
SYB 1 Erin Gundersen MS IV. Breast Cancer Breast Cancer.
SC430 Molecular Cell Biology
Classification Causes Diagnosis Grading Staging Effects/Surgical Tx
SYB Case 2 By: Amy. History 63 y/o female History of left breast infiltrating duct carcinoma s/p mastectomy in 1996 and chemotherapy ER negative, PR negative,
The Breast. Acute mastitis S. aureus Breastfeeding Fever, erythema, pain Periductal mastitis – subareolar mass, smoking, keratinizing Periductal mastitis.
Breast Carcinoma. Anatomy Epidemiology: 10% 17.1/10 28/10 46/ m world wide 6% develop cancer of the breast in their lifetime. 50,000 to 70,000.
Cancer Estimated US Cancer Cases Cancer Incidence Rates for Women, USA.
Endometrial Carcinoma
CANCER BREAST OVERVIEW Dr. Ehab M.Oraby. INTRODUCTION  Breast is a modified sweat gland between skin and pectoral fascia.
Putting the Puzzle Together: Breast Collaborative Staging Melissa Riddle, RHIT, CTR October 6, 2012.
Session 5. Case Diagnosis - Sclerosing adenosis with lobular neoplasia. No invasion in images provided.
Session 4. Biopsies. Professor Sarah Pinder. Case A - SP
Rare mammary gland diseases: a continuous challenge for the clinician
Ductal Carcinoma In Situ Shahla Masood, M.D. Professor of Pathology University of Florida College of Medicine - Jacksonville Chief of Pathology and Laboratory.
Changes in Breast Cancer Reports After Second Opinion Dr. Vicente Marco Department of Pathology Hospital Quiron Barcelona. Spain.
Breast Cancer Breast Cancer DR/FATMA AL-THOUBAITY ASSOCIATE PROFESSOR SURGICAL CONSULTANT.
Breast Pathology Emad Raddaoui, MD, FCAP, FASC
Breast disease MUDr. Petr Šafář, CSc.. Anatomy of female breast.
GASTRIC METASTASIS FROM BREAST CANCER: CASE REPORT Dott. Francesco Pontieri (*) UO di Anatomia Patologica P.O. di Rossano (CS) Dott. Gianluca Dima UO di.
Objectives Discuss the history of breast cancer. Describe the pathology of breast cancer and list significant tumor markers. Differentiate IHC testing.
By: Ashley Rodriguez, Yara parada, Briana Mendoza, Jackie Hernandez
 Among all cancers, breast cancer has been the 2 nd leading cause of death in women (right behind lung cancer)  Causes about 40,000 deaths annually.
Breast Cancer. Breast cancer is a disease in which malignant cells form in the tissues of the breast – “National Breast Cancer Foundation” The American.
EXPRESSION OF HER-2 CORRELATED PROTEINS IN ILEAL CARCINOIDS Azzoni C., Giordano G., Bottarelli L., Tamburini E., D’Adda T., Pizzi S., Rindi G., Bordi C.
Pathology.
Breast Carcinoma Dr. Ashraf A. Fatah Assistant professor
Preoperative staging of hilar cholangiocarcinoma by dual-modality PET/CT. DR SIKANDAR YASHODA HOSPITALS HYDERABAD.
Bile ducts Caroli disease  Congenital  Dysplasia with focal dialatations.
Annals of Oncology 23: 298–304, 2012 종양혈액내과 R4 김태영 / prof. 김시영.
Clear cell carcinoma of the ovary
Supraclavicular metastasis from urothelial bladder carcinoma: A case report S. Farmahan, T. Mirza, P. Ameerally Oral Maxillofacial Department, Northampton.
간담도 암에서의 PET 의 활용 핵의학과 홍일기. 18 F-FDG PET: Warburg effect.
CLINICAL ASPECT OF GRADING AND STAGING Hanggoro Tri Rinonce, MD, PhD Department of Anatomical Pathology Faculty of Medicine, Gadjah Mada University.
R2 김재민 / Prof. 정재헌 Journal conference 1.
GS Case M/53 S Small intestine, segmentectomy.
OVERVIEW OF BREAST PATHOLOGY Shahin Sayed, MMed, FCPath(ECSA) Assistant Professor, Department of Pathology, Aga Khan University Hospital, Nairobi.
Dr. Sura Obay Al-Dewachi
Chapter 14 Hepatic Tumors, Malignant 1
INTERNATIONAL CONFERENCE
سرطان الثدي Breast Cancer
Handling and Evaluation of Breast Cancer Biopsy
Histological and molecular heterogeneity of triple negative breast cancer (TNBC). Histological and molecular heterogeneity of triple negative breast cancer (TNBC).
Multiple (type 3) cyst-related primary lung malignancies presenting as cystic airspaces with asymmetrical or circumferential wall thickening. a, b) A 52-year-old.
CUP is a clinico-pathological syndrome of many specific cancer
Gene promoter methylation analysis in ductal lavage fluid from cancer-free women at high risk for breast cancer and in women undergoing mastectomy for.
Breast Cancer Screening in High-Risk Men: A 12-Year Longitudinal Observational Study of Male Breast Imaging Utilization and Outcomes Mammography screening.
Presentation transcript:

Division of Surgical, Molecular and Ultrastructural Pathology University of Pisa Pisa University Hospital Research Doctorate in Molecular and Experimental Oncology

UNKNOWN PRIMARY TUMORS a vanishing chapter of pathology

METASTASISPRIMARY ????????

CUP – Carcinoma of Unknown Primary UPC – Unknown Primary Cancer ACUP – Adeno Carcinoma of Unknown Primary    UPT – Unknown Primary Tumor  OPT – Occult Primary Tumor 

a biopsy-proven metastatic malignancy this diagnosis requires: after a thorough clinical evaluation that includes physical examination and laboratory and imaging diagnostic tests  no identifiable primary tumor 

 5 % of all metastatic cancer

CUP - UPC - UPT - OPT source identification:  - molecular profiling: 60 – 85 % - morphology, IHC: 20 – 30 % of cases

CUP - UPC - UPT - OPT prognosis:  worst than in cases with known primary

??????????? CUP - UPC - UPT - OPT

matter of size CUP - UPC - UPT - OPT

0 mm  few mm  CUP - UPC - UPT - OPT

0 mm: SPONTANEOUS REGRESSION  few mm  CUP - UPC - UPT - OPT

SPONTANEOUS REGRESSION of a TUMOR 1 : 60,000 – 100,000 cases ?????????????

SPONTANEOUS REGRESSION of a CANCER 1 : 60,000 – 100,000 cases ischemia ????????????? immune response “unofficial” chemical compounds   

Hicks AM et al: Transferable anticancer innate immunity in spontaneous regression/complete resistance mice. PNAS 103: 7753–7758, 2006

size imaging CUP - UPC - UPT - OPT

PRE – IMAGING ERA

The lesson of Anatomy of Dott. Nicolaes Tulp Rembrandt, 1632

Prof. Rupert A WILLIS in case of CUP - UPC - UPT - OPT LUNG

IMAGING & MOLECULAR PROFILING lung pancreas liver / bile ducts kidney / adrenals bowel genital system stomach bladder / ureter breast         

small very aggressive CUP - UPC - UPT - OPT

ductal; NOS: not otherwise specified; NST: no special type lobular tubular / cribriform medullary mucinous papillary metaplastic apocrine 80% 10% 6%6% 2%2% 2%2% 1% < 1% breast carcinoma        

DUCTALLOBULAR

sexual maturity aging pre-puberal

DCIS LCIS

INFILTRATING DUCTAL CARCINOMA DCIS: FREQUENT

LCIS: RARE INFILTRATING LOBULAR CARCINOMA

LOBULAR early loss of intercellular junctions DUCTAL late loss of intercellular junctions

terminal duct – lobule unit ductal carcinoma lobular carcinoma

DESTRUCTION of the LOBULE

natural history of a carcinoma 1 initiation:2 promotion: 3 progression: normal hyperplastic atypical cancer invasive metastatic

invasive cametastasis clones vascular invasion

CUP - UPC - UPT - OPT early acquisition of the invasive genotype / phenotype

CUP - UPC - UPT - OPT early acquisition of the invasive genotype / phenotype small primary early metastasis bad prognosis

PRIMARYMET or  =

PRIMARY MET molecular characterization for molecular therapy